Person:
ŞAHAN, EBRU

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
Organizational Unit
Job Title
First Name
EBRU
Last Name
ŞAHAN
Name
Email Address
Birth Date

Search Results

Now showing 1 - 3 of 3
  • PublicationMetadata only
    MODAFINIL INTOXICATION INDUCED PERSISTENT PSYCHOSIS: CASE REPORT
    (2019-01-01T00:00:00Z) ŞAHAN, EBRU; BÖLÜKBAŞI, Özgür; ŞAHAN, EBRU; BÖLÜKBAŞI, ÖZGÜR
  • PublicationMetadata only
    Oianzapine and tardive dyskinesia: a case report
    (2017-02-01T00:00:00Z) Sahan, EBRU; zengin eroğlu, Meliha; ŞAHAN, EBRU
    Tardive dyskinesia is a serious and common motor side-effect of treatment with especially traditional neuroleptics with an unknown pathophysiological basis. The essential features of neuroleptic-induced tardive dyskinesia (TD) are abnormal, involuntary movements of the tongue, jaw, trunk or extremities that emerges in a patient predisposed to antipsychotic medication. Although the exact pathogenesis of TD is unclear, there is some evidence that dopamine supersensitivity in the nigro-striatal pathway due to the antipsychotics could contribute to these dyskinetic movements. Atypical antipsychotics have less risk in terms of tardive dyskinesia compared to traditional neuroleptics however there is stil probability of late adverse effects. Although it has been suggested that olanzapine can improve tardive dyskinesia in some patients, few reported cases have shown that the prolonged use of olanzapine can instead be associated with tardive dyskinesia/dystonia. Here we report a case who experienced tardive dyskinesia after 12 years of treatment with olanzapine and its treatment with clozapine.
  • PublicationOpen Access
    Haloperidol-related neutropenia
    (2019-05-01T00:00:00Z) ŞAHAN, EBRU; ŞAHAN, EBRU
    Phenothiazines like antipsychotics have been known to cause neutropenia, but this has been reported very rarely with haloperidol. A 20-year-old male patient admitted to emergency service (emergency room) with shortness of breath, chest pain, and anger. He was diagnosed with pneumonia and prescribed moxifloxacin. After 2 days with antibiotic, he readmitted. Left lung pneumothorax was detected, and thorax computerized tomography was requested. However, he opposed and beated one of the hospital officials. The diagnosis of manic episode due to antibiotic moxifloxacin was considered. The tube thoracostomy had to be done, and antibiotic therapy was stopped. Haloperidol 10 mg/day and biperiden 4 mg/day injections were administered because he continued to resist medical interventions. After haloperidol, his leukocyte count decreased. He responded well to filgrastim (Neupogen) and blood transfusions, so a drug-related cause of neutropenia has been suspected. He was switched from haloperidol to quetiapine 300 mg twice a day. His white blood cell count returned to normal levels.